A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
Vertex Pharmaceuticals Incorporated · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018